EGFR and squamous cell carcinoma: The mouse monoclonal antibody (MAb) 225 was identified in 1983 as a potent inhibitor of EGF binding to EGFR, resulting in a significant decrease in proliferation of A431 epidermoid carcinoma cells displaying EGFR amplification [103].